The hydrolytic capacity of PDE4D is directly proportional to the inflammatory effect (Gurney et al., 2015; Ricciarelli et al., 2017), and we thus propose that the hydrolytic capacity of the PDE4D variants are significantly differs from that of the wild-type in the regions affected by inflammation during AD. Here, PDE4D is linked to Alzheimer disease.